Our long-term objective is to understand the molecular mechanism and physiological function of multiple DNA topoisomerases. In the current application, we propose to study the roles of the two human topoisomerase II (TOP2) isoforms in chromosomal loop domain organization and apoptotic cell death. Many TOP2-targeted anti-cancer drugs are known to induce apoptotic cell death and high molecular weight (HMW) DNA fragmentation (about 50 kb). These HMW DNA fragments presumably reflect TOP2-mediated excision of chromosomal loop domains in which TOP2 is located at their loop anchorage sites. Strikingly, a similar pattern of HMW DNA fragmentation (predominantly 50 kb) has also been observed in apoptotic cells induced by diverse stimuli many of which are known to induce oxidative stress. The HMW DNA fragmentation has been suggested to be a committed step in the apoptotic cell death process, but the enzyme responsible for HMW DNA fragmentation has not been identified. Our preliminary studies have demonstrated that the two human DNA TOP2 isoforms, TOP2a and TOP2b, can be activated to become DNA cleaving """"""""nucleases"""""""" by hydrogen peroxide, a reactive oxygen species (ROS) produced during oxidative stress. Oxidative stress has been suggested to be a potential cellular activation of TOP2b (and/or TOP2a) by hydrogen peroxide during oxidative stress is responsible for HMW DNA fragmentation in apoptotic cells. There are two major specific aims for the current application; (1). Functional studies of human TOP2 isoforms. Two approaches will be employed, identification of TOP2-interacting proteins and generating dominant negative mutant TOP2 cell lines. In addition to testing the roles of TOP2 isoforms in chromosomal loop domains mutated in patients with the Bloom's syndrome (genome instability) and WRN, mutated in patients with the Werner's syndrome (premature aging). (2). To establish the roles of human TOP2 isoforms in HMW DNA fragmentation during apoptotic cell death. We will determine if TOP2 ( and which TOP2 isoform) is activated into a """"""""nuclease"""""""" in cells treated with hydrogen peroxide or other agents. We will also determine which TOP2 isoform is responsible for HMW DNA fragmentation during apoptotic cell death.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM027731-20
Application #
6018516
Study Section
Molecular Cytology Study Section (CTY)
Project Start
1980-04-01
Project End
2002-06-30
Budget Start
1999-07-01
Budget End
2000-06-30
Support Year
20
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Pharmacology
Type
Schools of Medicine
DUNS #
622146454
City
Piscataway
State
NJ
Country
United States
Zip Code
08854
Qi, Haiyan; Li, Tsai-Kun; Kuo, Debbie et al. (2003) Inactivation of Cdc13p triggers MEC1-dependent apoptotic signals in yeast. J Biol Chem 278:15136-41
Zhou, Nai; Xiao, Hai; Li, Tsai-Kun et al. (2003) DNA damage-mediated apoptosis induced by selenium compounds. J Biol Chem 278:29532-7
Xiao, Hai; Li, Tsai-Kun; Yang, Jin-Ming et al. (2003) Acidic pH induces topoisomerase II-mediated DNA damage. Proc Natl Acad Sci U S A 100:5205-10
Xiao, Hai; Mao, Yong; Desai, Shyamal D et al. (2003) The topoisomerase IIbeta circular clamp arrests transcription and signals a 26S proteasome pathway. Proc Natl Acad Sci U S A 100:3239-44
Nur-E-Kamal, Alam; Li, Tsai-Kun; Zhang, Ailing et al. (2003) Single-stranded DNA induces ataxia telangiectasia mutant (ATM)/p53-dependent DNA damage and apoptotic signals. J Biol Chem 278:12475-81
Wang, H; Mao, Y; Zhou, N et al. (2001) Atp-bound topoisomerase ii as a target for antitumor drugs. J Biol Chem 276:15990-5
Wang, H; Mao, Y; Chen, A Y et al. (2001) Stimulation of topoisomerase II-mediated DNA damage via a mechanism involving protein thiolation. Biochemistry 40:3316-23
Li, T K; Liu, L F (2001) Tumor cell death induced by topoisomerase-targeting drugs. Annu Rev Pharmacol Toxicol 41:53-77
Sim, S P; Liu, L F (2001) Nucleolytic cleavage of the mixed lineage leukemia breakpoint cluster region during apoptosis. J Biol Chem 276:31590-5
Mao, Y; Desai, S D; Ting, C Y et al. (2001) 26 S proteasome-mediated degradation of topoisomerase II cleavable complexes. J Biol Chem 276:40652-8

Showing the most recent 10 out of 50 publications